A Pilot Phase 2 Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Advanced Malignant Mesothelioma.
Phase of Trial: Phase II
Latest Information Update: 30 May 2017
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Mesothelioma
- Focus Therapeutic Use
- 23 May 2016 Status changed from active, no longer recruiting to completed.
- 07 May 2015 Planned End Date changed from 1 Mar 2016 to 1 Apr 2016 as reported by ClinicalTrials.gov record.
- 07 May 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.